Let's not forget their very profitable exit stage left in 2022 either @ 75 cents
![]()
You would think that with the expertise and the contacts of the Mesoblast management team that they would be able to come up with an alternative at this stage of the game / progress in the last 6 months ..... I guess we will see in the coming weeks or shortly (sorry I couldn't resist those quotes)
GLTAH
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-219
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
-0.010(1.03%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $2.128M | 2.205M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 69818 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 94121 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 62119 | 0.955 |
22 | 161251 | 0.950 |
20 | 240631 | 0.945 |
14 | 229646 | 0.940 |
13 | 339516 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 100976 | 30 |
0.965 | 168588 | 26 |
0.970 | 174774 | 14 |
0.975 | 128486 | 9 |
0.980 | 239173 | 9 |
Last trade - 15.01pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online